Skip to main content

Advertisement

ADVERTISEMENT

Conference Coverage

Marla Dubinsky, MD
Podcast
09/11/2021
In this podcast, Marla Dubinsky, MD, discusses highlights from her presentation on Pregnancy and Inflammatory Bowel Disease, and Neonatal Outcomes—Lessons in Pregnancy, during the AIBD Regional virtual conference.
In this podcast, Marla Dubinsky, MD, discusses highlights from her presentation on Pregnancy and Inflammatory Bowel Disease, and Neonatal Outcomes—Lessons in Pregnancy, during the AIBD Regional virtual conference.
In this podcast, Marla Dubinsky,...
09/11/2021
Advances in Inflammatory Bowel Disease Network
Dr David Rubin
Conference Coverage
09/11/2021
At the Advances in Inflammatory Bowel diseases virtual regional meeting on September 11, Dr Rubin discussed the challenges of caring for patients with severe ulcerative colitis.
At the Advances in Inflammatory Bowel diseases virtual regional meeting on September 11, Dr Rubin discussed the challenges of caring for patients with severe ulcerative colitis.
At the Advances in Inflammatory...
09/11/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Amy Lightner
Conference Coverage
09/11/2021
Amy Lightner, MD, colorectal surgeon at Cleveland Clinic, discussed the difficulties in treating perianal Crohn disease, and new alternative therapies on the horizon at the Advances in Inflammatory Bowel Disease virtual regional meeting on...
Amy Lightner, MD, colorectal surgeon at Cleveland Clinic, discussed the difficulties in treating perianal Crohn disease, and new alternative therapies on the horizon at the Advances in Inflammatory Bowel Disease virtual regional meeting on...
Amy Lightner, MD, colorectal...
09/11/2021
Advances in Inflammatory Bowel Disease Network
Bruce Sands, MD
Conference Coverage
09/11/2021
Ustekinumab provides a safe and effective therapeutic agent for inflammatory bowel disease, and upcoming interleukin 23 inhibitors may be better yet, said Dr Sands at the Advances in Inflammatory Bowel Diseases virtual regional meeting on...
Ustekinumab provides a safe and effective therapeutic agent for inflammatory bowel disease, and upcoming interleukin 23 inhibitors may be better yet, said Dr Sands at the Advances in Inflammatory Bowel Diseases virtual regional meeting on...
Ustekinumab provides a safe and...
09/11/2021
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
09/11/2021
Janus kinase inhibitors are poised to meet significant unmet needs for treatment of inflammatory bowel diseases, Dr Rubin said at the Advances in Inflammatory Bowel Diseases virtual regional meeting on September 11.
Janus kinase inhibitors are poised to meet significant unmet needs for treatment of inflammatory bowel diseases, Dr Rubin said at the Advances in Inflammatory Bowel Diseases virtual regional meeting on September 11.
Janus kinase inhibitors are...
09/11/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

Dr Ungaro
Video
09/11/2021
In this video, Ryan Ungaro, MD, discusses highlights from his presentation on the Optimal Use of Anti-Integrins and Anti-TNFs for the Management of IBD, presented during the AIBD Regional virtual conference on September 11.
In this video, Ryan Ungaro, MD, discusses highlights from his presentation on the Optimal Use of Anti-Integrins and Anti-TNFs for the Management of IBD, presented during the AIBD Regional virtual conference on September 11.
In this video, Ryan Ungaro, MD,...
09/11/2021
Advances in Inflammatory Bowel Disease Network
Dr Bruce Sands
Conference Coverage
09/11/2021
The future of combination therapy in inflammatory bowel disease may lie in using multiple biologics rather than immunomodulators, Dr Sands told the September 11 regional meeting of AIBD.
The future of combination therapy in inflammatory bowel disease may lie in using multiple biologics rather than immunomodulators, Dr Sands told the September 11 regional meeting of AIBD.
The future of combination...
09/11/2021
Advances in Inflammatory Bowel Disease Network
Dr Emanuelle Bellaguarda
Conference Coverage
08/07/2021
In this video, Dr Emanuelle Bellaguarda recaps her presentation at the Advances in Inflammatory Bowel Disease regional meeting held on August 7, on Diet as Therapy for Inflammatory Bowel Disease (IBD).
In this video, Dr Emanuelle Bellaguarda recaps her presentation at the Advances in Inflammatory Bowel Disease regional meeting held on August 7, on Diet as Therapy for Inflammatory Bowel Disease (IBD).
In this video, Dr Emanuelle...
08/07/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

David Rubin, MD
Conference Coverage
08/07/2021
Low immunogenicity, effectiveness among patients who have failed with anti-TNFs, make ustekinumab a good choice for both Crohn disease and ulcerative colitis, David T. Rubin, MD, explained at AIBD 2021 regional.
Low immunogenicity, effectiveness among patients who have failed with anti-TNFs, make ustekinumab a good choice for both Crohn disease and ulcerative colitis, David T. Rubin, MD, explained at AIBD 2021 regional.
Low immunogenicity,...
08/07/2021
Advances in Inflammatory Bowel Disease Network
Dr Marla Dubinsky
Conference Coverage
08/07/2021
Dr Marla Dubinsky, from the Icahn School of Medicine in New York, discussed the importance in considering when and how clinicians should use JAK inhibitors in treating inflammatory bowel disease during her recent presentation at AIBD...
Dr Marla Dubinsky, from the Icahn School of Medicine in New York, discussed the importance in considering when and how clinicians should use JAK inhibitors in treating inflammatory bowel disease during her recent presentation at AIBD...
Dr Marla Dubinsky, from the...
08/07/2021
Advances in Inflammatory Bowel Disease Network

Advertisement